Notice of transactions by persons discharging managerial responsibility
As set out in the Company's 2019 Annual Report, and in the RNS on 1 November 2019 detailing an initial grant of deferred share awards in respect of the Executive Directors' annual bonuses for FY19, the Board was seeking shareholder approval for a resolution at the AGM on 5 December 2019 to amend the remuneration policy to allow up to 100% of any annual bonus earned to be paid in deferred share awards. The previous policy was a maximum of 50% in deferred shares with the balance to be paid in cash. The Board consider this change to be in the best interests of the Company by creating additional scope to conserve cash resources.
The relevant resolution was approved by shareholders at the AGM on 5th December 2019 with 99.8% of votes cast in favour. Subject to and following this approval, Nanoco has now granted to the Executive Directors, nil-cost options over ordinary shares in the Company in respect of the second half their annual bonus awards for FY19 as set out below.
Name of Director
Number of options granted
Michael Edelman (CEO)
Nigel Pickett (CTO)
Brian Tenner (COO / CFO)
For the avoidance of doubt, the approved policy amendment had no impact on the actual amount or maximum amount of bonus that was earned in FY19 or can be earned in future years.
Ordinarily, the options will vest following the announcement of Nanoco's results for its financial year ending 31 July 2021. There are no further performance conditions attached to these options.
This notification is made pursuant to Disclosure and Transparency Rule 3.1.4. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Nanoco (LSE: NANO) harnesses the power of nano-materials through an extensive and unique IP portfolio of over 750 patents and patents pending with world leading R&D capabilities and high capacity production facilities. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.
Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.
Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.
Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
Notification of Dealing Form
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
Reason for the notification
CHIEF EXECUTIVE OFFICER
Initial notification / amendment
Details of the Issuer
NANOCO GROUP PLC
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Type of instrument: Identification code
OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH
Nature of the transaction
GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...